JUDY MAGNUSSON: Open Payments
NPI 1396718326 · OKLAHOMA CITY, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,646 in 79 payments from 20 companies in 2025. Trend: 2023 $2,067 · 2024 $1,545 · 2025 $1,646
Food & beverage: $1,646
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 8 | $355 |
| Otsuka America Pharmaceutical, Inc. | 12 | $232 |
| Novo Nordisk Inc | 15 | $216 |
| Lilly USA, LLC | 13 | $213 |
| PFIZER INC. | 6 | $100 |
| Axsome Therapeutics, Inc. | 3 | $79 |
| Insulet Corporation | 3 | $63 |
| Corcept Therapeutics | 3 | $62 |
| KYOWA KIRIN, INC. | 2 | $57 |
| Exact Sciences Corporation | 2 | $38 |
Products named: AIRSUPRA, REXULTI, Ozempic, MOUNJARO, JARDIANCE, Wegovy, Auvelity, FARXIGA.
Industry payments across OK — which companies pay providers there.
